Journals / Clinical Dentistry and Research / 2016 / Cilt: 40 - Sayı: 2

KRONİK VE AGRESİF PERİODONTİTİSLİ HASTALARDA PERİODONTAL CERRAHİNİN OSTEOİMMÜNOLOJİK MEDYATÖRLERE ETKİSİ

EFFECT OF PERIODONTAL SURGERY ON THE OSTEOIMMUNOLOGICAL MEDIATORS IN PATIENTS WITH CHRONIC AND AGGRESSIVE PERIODONTITIS

Pages
49–59
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Even though the surgical periodontal treatment improved periodontal clinical parameters significantly, the present findings suggested that, it did not seem to have a meaningful effect on osteoimmunological mediators except interleukin-1?.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Background and Aim: Increased levels of receptor activator of nuclear factor kappa-B ligand (RANKL) and RANKL/OPG (osteoprotegerin) ratio in untreated periodontitis have been presented.
📊
Key Findings & Data:This study, aims to determine the RANKL, OPG, interleukin-1 beta (?), interleukin-10 levels in gingival crevicular fluid before and after surgical periodontal treatment in chronic and aggressive periodontitis.Subjects and Methods: Sixteen chronic periodontitis patients, 10 localized and 13 generalized aggressive periodontitis patients and 18 periodontally healthy controls were included.
💡
Conclusion & Impact:Even though the surgical periodontal treatment improved periodontal clinical parameters significantly, the present findings suggested that, it did not seem to have a meaningful effect on osteoimmunological mediators except interleukin-1?.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Background and Aim: Increased levels of receptor activator of nuclear factor kappa-B ligand (RANKL) and RANKL/OPG (osteoprotegerin) ratio in untreated periodontitis have been presented. However, current knowledge of periodontal treatment on osteoimmunological results is scarce. This study, aims to determine the RANKL, OPG, interleukin-1 beta (?), interleukin-10 levels in gingival crevicular fluid before and after surgical periodontal treatment in chronic and aggressive periodontitis.Subjects and Methods: Sixteen chronic periodontitis patients, 10 localized and 13 generalized aggressive periodontitis patients and 18 periodontally healthy controls were included. Clinical periodontal parameters were recorded and gingival crevicular fluid was collected at baseline and 3 months after open flap surgery. RANKL, OPG, interleukin-1?, interleukin-10 levels were analysed by enzyme linked immunosorbent assay.Results: RANKL total amount and RANKL/OPG ratio were higher in disease groups than controls at baseline. RANKL/OPG, Interleukin1?/Interleukin-10 ratios did not change after treatment for all periodontitis groups while Interleukin-1? total amount decreased (p<0.05). RANKL total amount was significantly decreased in generalized aggressive periodontitis group (p<0.05) while remaining similar in other groups.Conclusions: Increased RANKL total levels and RANKL/OPG ratio in untreated chronic and aggressive periodontitis groups supported its role in periodontal bone destruction. Even though the surgical periodontal treatment improved periodontal clinical parameters significantly, the present findings suggested that, it did not seem to have a meaningful effect on osteoimmunological mediators except interleukin-1?.

Özet

Amaç: Tedavi edilmemiş periodontitiste nükleer faktör kappa B-ligand (RANKL) seviyesi ve RANKL/OPG (osteoprotegerin) oranının artmış olduğu gösterilmiştir. Ancak, periodontal tedavinin osteoimmünolojik sonuçlara etkisi üzerindeki bilgilerimiz henüz kısıtlıdır. Bu çalışma, kronik ve agresif periodontitis hastalarında, diş eti oluğu sıvısındaki RANKL, OPG, interlökin-1 beta (?), interlökin-10 seviyelerini, cerrahi tedavi öncesi ve sonrası belirlemeyi amaçlamaktadır.Bireyler ve Yöntem: On altı kronik periodontitisli hasta, 10 lokalize ve 13 generalize agresif periodontitis hastası ve 18 periodontal sağlıklı kontrol dahil edilmiştir. Başlangıç ile flep cerrahisinden sonraki 3. ayda, klinik periodontal parametreler kaydedilmiş ve diş eti oluğu sıvısı toplanmıştır. RANKL, OPG, interlökin-1 beta (?), interlökin-10 seviyeleri enzim ilintili immün test ile analiz edilmiştir. Bulgular: RANKL total miktarı ve RANKL/OPG oranı başlangıçta, hastalık gruplarında kontrol grubuna göre daha yüksektir. İnterlökin-1? total miktarı azalırken (p<0.05), RANKL/OPG, İnterlökin-1?/İnterlökin-10 oranları, tüm periodontitis grupları için tedavi sonrasında değişiklik göstermemiştir. RANKL total miktarı, diğer gruplarda benzer kalırken, generalize agresif periodontitis grubunda anlamlı olarak azalmıştır. Sonuç: Tedavi edilmemiş periodontitiste total RANKL değerlerinin ve RANKL/OPG (osteoprotegerin) oranının artmış olması, bu sitokinin periodontal kemik yıkımındaki rolünü desteklemiştir. Periodontal klinik parametrelerde anlamlı bir gelişme sağlamasına rağmen, mevcut bulgular, cerrahi periodontal tedavinin interlökin1? dışındaki diğer osteoimmünolojik medyatörlere anlamlı bir etkisinin olmadığını göstermektedir.

🔖

Cite This Article

İLARSLAN, Y. D., ERMAN, B., KARABULUT, E., TEZCAN, İ., BERKER, E. (2016). KRONİK VE AGRESİF PERİODONTİTİSLİ HASTALARDA PERİODONTAL CERRAHİNİN OSTEOİMMÜNOLOJİK MEDYATÖRLERE ETKİSİ. Clinical Dentistry and Research, Cilt: 40 - Sayı: 2, 49–59. https://ajindex.com/articles/160494

References (9)

  1. Okada H, Murakami S. Cytokine expression in periodontal health and disease. Crit Rev Oral Biol Med 1998; 9: 248-266. Teng YT. Protective and destructive immunity in the periodontium: Part 2--T-cell-mediated immunity in the periodontium. J Dent Res 2006; 85: 209-219.
  2. Boch JA, Wara-aswapati N, Auron PE. Interleukin 1 signal transduction--current concepts and relevance to periodontitis. J Dent Res 2001; 80: 400-407.
  3. Ebersole JL, Singer RE, Steffensen B, Filloon T, Kornman KS. Inflammatory mediators and immunoglobulins in GCF from healthy, gingivitis and periodontitis sites. J Periodontal Res 1993; 28: 543-546.
  4. Rawlinson A, Dalati MH, Rahman S, Walsh TF, Fairclough AL. Interleukin-1 and IL-1 receptor antagonist in gingival crevicular fluid. J Clin Periodontol 2000; 27: 738-743.
  5. Delima AJ, Karatzas S, Amar S, Graves DT. Inflammation and tissue loss caused by periodontal pathogens is reduced by interleukin-1 antagonists. J Infect Dis 2002; 186: 511-516. de Lima Oliveira AP, de Faveri M, Gursky LC, Mestnik M. J, Feres M, Haffajee A. D. et al. Effects of periodontal therapy on GCF cytokines in generalized aggressive periodontitis subjects. J Clin Periodontol; 39: 295-302.
  6. Sattari M, Fathiyeh A, Gholami F, Darbandi Tamijani H, Ghatreh Samani M. Effect of surgical flap on IL-1beta and TGF-beta concentrations in the gingival crevicular fluid of patients with moderate to severe chronic periodontitis. Iran J Immunol 2011; 8: 26. Delima AJ, Oates T, Assuma R, Schwartz Z, Cochran D, Amar S. et al. Soluble antagonists to interleukin-1 (IL-1) and tumor necrosis factor (TNF) inhibits loss of tissue attachment in experimental periodontitis. J Clin Periodontol 2001; 28: 233-240.
  7. Cassatella MA, Meda L, Bonora S, Ceska M, Constantin G. Interleukin 10 (IL-10) inhibits the release of proinflammatory cytokines from human polymorphonuclear leukocytes. Evidence for an autocrine role of tumor necrosis factor and IL-1 beta in mediating the production of IL-8 triggered by lipopolysaccharide. J Exp Med 1993; 178: 2207-2211.
  8. Lacraz S, Nicod LP, Chicheportiche R, Welgus HG, Dayer JM. IL- inhibits metalloproteinase and stimulates TIMP-1 production in human mononuclear phagocytes. J Clin Invest 1995; 96: 2304 Sasaki H, Suzuki N, Kent R, Jr., Kawashima N, Takeda J, Stashenko P. T cell response mediated by myeloid cell-derived IL-12 is responsible for Porphyromonas gingivalis-induced periodontitis in IL-10-deficient mice. J Immunol 2008; 180: 6193-6198.
  9. Berker E, Kantarci A, Hasturk H, Van D